FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 804-810

  Ando, Seiichiro ^a   Amano, Hirofumi ^a   Amano, Eri ^a   Minowa, Kentaro ^a   Watanabe, Takashi ^a   Nakano, Soichiro ^a   Nakiri, Yutaka ^a   Morimoto, Shinji ^a   Tokano, Yoshiaki ^a   Lin, Qingshun ^a   Hou, Rong ^a   Ohtsuji, Mareki ^a   Tsurui, Hiromichi ^a   Hirose, Sachiko ^a   Takasaki, Yoshinari ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BXSB mice; FTY720; Lupus nephritis; SLE; Sphingosine 1 phosphate (S1P) receptors

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; FINGOLIMOD; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE DEPLETION; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTES; MESANGIAL CELLS; MICE; MONOCYTES; PROPYLENE GLYCOLS; SPHINGOSINE; SPLEEN;

MUS;

EID: 77950518272     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.078     Document Type: Article

References (26)

1. Chiba K., Yanagawa Y., Masubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., and Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160 (1998) 5037-5044
2. Brinkmann V., and Lynch K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 14 (2002) 569-575
3. Rosen H., Sanna G., and Alfonso C. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev. 195 (2003) 160-177
4. Graler M.H., and Goetzl E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18 (2004) 551-553
5. Kappos L., Antel J., Comi G., Montalban X., O'Connor P., Polman C.H., Haas T., Korn A.A., Karlsson G., and Radue E.W. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355 (2006) 1124-1140
6. Budde K., Schmouder R.L., Brunkhorst R., Nashan B., Lucker P.W., Mayer T., Choudhury S., Skerjanec A., Kraus G., and Neumayer H.H. First human trial of FTY720. A novel immunomodulator, in stable renal transplant patients. J. Am. Soc. Nephrol. 13 (2002) 1073-1083
7. Okazaki H., Hirata D., Kamimura T., Sato H., Iwamoto M., Yoshio T., Masuyama J., Fujimura A., Kobayashi E., Kano S., and Minota S. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J. Rheumatol. 29 (2002) 707-716
8. Alperovich G., Rama I., Lloberas N., Franquesa M., Poveda R., Goma M., Herrero-Fresneda I., Cruzado J.M., Bolanos N., Carrera M., Grinyo J.M., and Torras J. New immunosuppressor strategies in the treatment of murine lupus nephritis. Lupus 16 (2007) 18-24
9. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J., Murphy E.D., Roths J.B., and Dixon F.J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148 (1978) 1198-1215
10. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., and Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 (2006) 1669-1672
11. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., Liang C., Bartov G., McDaniel L.D., Zhou X.J., Schultz R.A., and Wakeland E.K. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103 (2006) 9970-9975
12. Wofsy D., Kerger C.E., and Seaman W.E. Monocytosis in the BXSB model for systemic lupus erythematosus. J. Exp. Med. 159 (1984) 629-634
13. Amano H., Amano E., Moll T., Marinkovic D., Ibnou-Zekri N., Martinez-Soria E., Semac I., Wirth T., Nitschke L., and Izui S. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol. 170 (2003) 2293-2301
14. Cinamon G., Matloubian M., Lesneski M.J., Xu Y., Low C., Lu T., Proia R.L., and Cyster J.G. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5 (2004) 713-720
15. Palframan R.T., Jung S., Cheng G., Weninger W., Luo Y., Dorf M., Littman D.R., Rollins B.J., Zweerink H., Rot A., and von Andrian U.H. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194 (2001) 1361-1373
16. Lu T.T., and Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297 (2002) 409-412
17. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5 (2005) 560-570
18. Singer I.I., Tian M., Wickham L.A., Lin J., Matheravidathu S.S., Forrest M.J., Mandala S., and Quackenbush E.J. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol. 175 (2005) 7151-7161
19. Hora K., Satriano J.A., Santiago A., Mori T., Stanley E.R., Shan Z., and Schlondorff D. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc. Natl. Acad. Sci. USA 89 (1992) 1745-1749
20. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
21. Lin Q., Xiu Y., Jiang Y., Tsurui H., Nakamura K., Kodera S., Ohtsuji M., Ohtsuji N., Shiroiwa W., Tsukamoto K., Amano H., Amano E., Kinoshita K., Sudo K., Nishimura H., Izui S., Shirai T., and Hirose S. Genetic dissection of the effects of stimulatory and inhibitory IgG Fc receptors on murine lupus. J. Immunol. 177 (2006) 1646-1654
22. Bergtold A., Gavhane A., D'Agati V., Madaio M., and Clynes R. FcR-bearing myeloid cells are responsible for triggering murine nephritis. J. Immunol. 177 (2006) 7287-7295
23. Yatomi Y., Igarashi Y., Yang L., Hisano N., Qi R., Asazuma N., Satoh K., Ozaki Y., and Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121 (1997) 969-973
24. Hanafusa N., Yatomi Y., Yamada K., Hori Y., Nangaku M., Okuda T., Fujita T., Kurokawa K., and Fukagawa M. Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. Nephrol. Dial. Transplant. 17 (2002) 580-586
25. Ikezumi Y., Hurst L.A., Masaki T., Atkins R.C., and Nikolic-Paterson D.J. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int. 63 (2003) 83-95
26. Kamanna V.S., Bassa B.V., Ganji S.H., and Roh D.D. Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. Histol. Histopathol. 20 (2005) 603-613